Stock NEUN NEUROGENESIS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Neurogenesis, Inc.

Equities

NEUN

US64124F3010

Market Closed - OTC Markets
Other stock markets
 19:49:23 12/06/2024 BST 		5-day change 1st Jan Change
0.0001 USD -.--% Intraday chart for Neurogenesis, Inc. -.--% -.--%
2023 Neurogenesis, Inc. Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome CI
2021 Neurogene Inc. and University of Edinburgh Announces Research Collaboration to Advance Next Generation Gene Therapies CI
f79c0de91b5b3.jDDcHQVfbfZsjAh4cgrOU1VHbmQbv7TDyaj-e79-Xm4.uQi7QmAMIIMhyX5NR06hAWF-LCEt787yiPGZOvg9HVj_eOUpUgtUsA7ASQ~bf9e7acae954d5c109f30babfb0541a1
  1. Stock Market
  2. Equities
  3. NEUN Stock
  4. Charts Neurogenesis, Inc.
  5. News Chart